[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
November 26, 2001

PDR Provides Latest Food and Drug Administration–Approved Dosage Guidelines

Arch Intern Med. 2001;161(21):2622. doi:

Please permit us to correct some misconceptions regarding the Physicians' Desk Reference (PDR) appearing in the article "Adverse Drug Effects, Compliance, and Initial Doses of Antihypertensive Drugs Recommended by the Joint National Committee vs the Physicians' Desk Reference," by Cohen in the March 26, 2001, issue of the ARCHIVES.1 The PDR is designed as a communication vehicle to deliver Food and Drug Administration–approved prescribing information from pharmaceutical manufacturers to physicians and other health care professionals.

First Page Preview View Large
First page PDF preview
First page PDF preview
×